Recall | Medicines | 20/11/2018

The marketing authorization holder has informed its supplied customers in a letter dated November 16, 2018, that isolated impurities or contamination of the film-coated tablets have been detected, which occurred during the packaging of the film-coated tablets into the blisters. The batch AV069 is therefore recalled as a precautionary measure.

Name of the medicinal product Novalgin Filmtabletten
Marketing authorisation number(s) 3192
Marketing authorisation holder Sanofi - Aventis GmbH
Batch number(s) AV069
Classification of the recall3
BASG reference number INS-640.001-2605

Further inquiry note